Home/Filings/4/0001415889-16-005181
4//SEC Filing

MetaStat, Inc. 4

Accession 0001415889-16-005181

CIK 0001404943operating

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 9:00 PM ET

Size

5.4 KB

Accession

0001415889-16-005181

Insider Transaction Report

Form 4
Period: 2016-02-03
Schneiderman Daniel H
Vice President of Finance
Transactions
  • Award

    Options to purchase Common Stock

    2016-02-03+20,00020,000 total
    Exercise: $3.55Exp: 2026-02-03Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]5,000 of such stock options vested upon issuance and 15,000 stock options vest upon release of clinical data in connection with the company's ECOG 2197 breast cancer clinical trial.

Issuer

MetaStat, Inc.

CIK 0001404943

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001404943

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 9:00 PM ET
Size
5.4 KB